LKB1-AMPK signaling in muscle from obese insulin-resistant Zucker rats and effects of training
Authors:
- John L. IvyJIJohn L. Ivy
- Christine Christ-RobertsCCChristine Christ-Roberts
- Ralph A. DeFronzoRDRalph A. DeFronzo
- Lawrence J. MandarinoLMLawrence J. Mandarino
- Nicolas MusiNMNicolas Musi
- 1 May 2006
- journal article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 290 (5) , E925-E932
Abstract
AMPK is a key regulator of fat and carbohydrate metabolism. It has been postulated that defects in AMPK signaling could be responsible for some of the metabolic abnormalities of type 2 diabetes. In this study, we examined whether insulin-resistant obese Zucker rats have abnormalities in the AMPK pathway. We compared AMPK and ACC phosphorylation and the protein content of the upstream AMPK kinase LKB1 and the AMPK-regulated transcriptional coactivator PPARγ coactivator-1 (PGC-1) in gastrocnemius of sedentary obese Zucker rats and sedentary lean Zucker rats. We also examined whether 7 wk of exercise training on a treadmill reversed abnormalities in the AMPK pathway in obese Zucker rats. In the obese rats, AMPK phosphorylation was reduced by 45% compared with lean rats. Protein expression of the AMPK kinase LKB1 was also reduced in the muscle from obese rats by 43%. In obese rats, phosphorylation of ACC and protein expression of PGC-1α, two AMPK-regulated proteins, tended to be reduced by 50 ( P = 0.07) and 35% ( P = 0.1), respectively. There were no differences in AMPKα1, -α2, -β1, -β2, and -γ3 protein content between lean and obese rats. Training caused a 1.5-fold increase in AMPKα1 protein content in the obese rats, although there was no effect of training on AMPK phosphorylation and the other AMPK isoforms. Furthermore, training also significantly increased LKB1 and PGC-1α protein content 2.8- and 2.5-fold, respectively, in the obese rats. LKB1 protein strongly correlated with hexokinase II activity ( r = 0.75, P = 0.001), citrate synthase activity ( r = 0.54, P = 0.02), and PGC-1α protein content ( r = 0.81, P < 0.001). In summary, obese insulin-resistant rodents have abnormalities in the LKB1-AMPK-PGC-1 pathway in muscle, and these abnormalities can be restored by training.Keywords
This publication has 67 references indexed in Scilit:
- AMP-activated protein kinase kinase activity and phosphorylation of AMP-activated protein kinase in contracting muscle of sedentary and endurance-trained ratsAmerican Journal of Physiology-Endocrinology and Metabolism, 2005
- Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contractionThe EMBO Journal, 2005
- Effects of α‐AMPK knockout on exercise‐induced gene activation in mouse skeletal muscleThe FASEB Journal, 2005
- AMP kinase is not required for the GLUT4 response to exercise and denervation in skeletal muscleAmerican Journal of Physiology-Endocrinology and Metabolism, 2004
- Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 DiabetesNew England Journal of Medicine, 2004
- AMPK activity and isoform protein expression are similar in muscle of obese subjects with and without type 2 diabetesAmerican Journal of Physiology-Endocrinology and Metabolism, 2004
- Cloning and characterization of mouse 5′-AMP-activated protein kinase γ3 subunitAmerican Journal of Physiology-Cell Physiology, 2004
- MO25α/β interact with STRADα/β enhancing their ability to bind, activate and localize LKB1 in the cytoplasmThe EMBO Journal, 2003
- PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetesNature Genetics, 2003
- Contraction Regulation of Akt in Rat Skeletal MuscleJournal of Biological Chemistry, 2002